2012•Yanke xinjinzhanRequires access

Curative effect of intravitreal injection of infliximab on experimental autoimmune uveitis

Zhao Xu, Gao Xiao

Open publisher page 0 citations

Abstract

Objective To investigate the curative effect of intravitreal injection of infliximab on experimental autoimmune uveitis(EAU).Methods Thirty-two female New Zealand rabbits were randomly divided into three groups.Treatment group had 16 rabbits,the model control group and normal control group had 8 rabbits respectively.EAU animal model of acute ocular inflammation was induced by bovine serum albumin(BSA).The model control group and treatment group received intravitreal injection and intravenous injection of BSA.The day after the models were operated successfully,the model control group,treatment group and normal control group were applied with NS(0.1 mL),10 g·L-1 infliximab(0.1 mL) and NS(0.1 mL) through intravitreal injection respectively.Each group was injected once.The aqueous humor of both eyes were collected separately before the rabbits were sacrificed before operation and 5 days,10 days and 15 days after operation.Meanwhile,the ocular expression was examined.ELISA method was used to detect contents of tumor necrosis factor-α(TNF-α) and interleukin-2(IL-2).The both eyes were used for histopathological examination.Results Before modeling,the level of TNF-α and IL-2 in aqueous humor among three groups was no statistical difference.At 5 days,10 days and 15 days after operation,the model control group and treatment group were significantly higher than normal control group.No significant difference was found between the model control group and treatment group at 5 days after operation(P0.05).Furthermore,at 10 days and 15 days after operation,the level of TNF-α in the model control group were(652.29±102.76)ng·L-1 and(372.63±47.59)ng·L-1,while in the treatment group the level was declined significantly to(395.88±48.97)ng·L-1 and(140.44±41.69)ng·L-1(P0.05).The level of IL-2 declined significantly to(40.89±8.81)ng·L-1 and(26.48±7.71)ng·L-1 compared to the model control group(85.55±7.74)ng·L-1 and(64.10±7.78)ng·L-1.There were no signs or pathologic change in all the rabbits in the normal control group.The histopathological examination of treatment group suggested that the inflammation significantly relieved compared to the model control group.Conclusion Infliximab can obviously inhibit the formation of TNF-α and IL-2 in aqueous humor of BAS induced EAU models,and release EAU inflammatory reaction and histological injury that can be applied to control EAU.

About this research paper

What this paper is about

Objective To investigate the curative effect of intravitreal injection of infliximab on experimental autoimmune uveitis(EAU).Methods Thirty-two female New Zealand rabbits were randomly divided into three groups.Treatment group had 16 rabbits,the model control group and normal control group had 8 rabbits respectively.EAU animal model of acute ocular inflammation was induced by bovine serum albumin(BSA).The model control group and treatment group received intravitreal injection and intravenous injection of BSA.The day after the models were operated successfully,the model control group,treatment group and normal control group were applied with NS(0.1 mL),10 g·L-1 infliximab(0.1 mL) and NS(0.1 mL) through intravitreal injection respectively.Each group was injected once.The aqueous humor of both eyes were collected separately before the rabbits were sacrificed before operation and 5 days,10 days and 15 days after operation.Meanwhile,the ocular expression was examined.ELISA method was used to detect contents of tumor necrosis factor-α(TNF-α) and interleukin-2(IL-2).The both eyes were used for histopathological examination.Results Before modeling,the level of TNF-α and IL-2 in aqueous humor among three groups was no statistical difference.At 5 days,10 days and 15 days after operation,the model control group and treatment group were significantly higher than normal control group.No significant difference was found between the model control group and treatment group at 5 days after operation(P0.05).Furthermore,at 10 days and 15 days after operation,the level of TNF-α in the model control group were(652.29±102.76)ng·L-1 and(372.63±47.59)ng·L-1,while in the treatment group the level was declined significantly to(395.88±48.97)ng·L-1 and(140.44±41.69)ng·L-1(P0.05).The level of IL-2 declined significantly to(40.89±8.81)ng·L-1 and(26.48±7.71)ng·L-1 compared to the model control group(85.55±7.74)ng·L-1 and(64.10±7.78)ng·L-1.There were no signs or pathologic change in all the rabbits in the normal control group.The histopathological examination of treatment group suggested that the inflammation significantly relieved compared to the model control group.Conclusion Infliximab can obviously inhibit the formation of TNF-α and IL-2 in aqueous humor of BAS induced EAU models,and release EAU inflammatory reaction and histological injury that can be applied to control EAU.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the curative effect of intravitreal injection of infliximab on experimental autoimmune uveitis(EAU).Methods Thirty-two female New Zealand rabbits were randomly divided into three groups.Treatment group had 16 rabbits,the model control group and normal control group had 8 rabbits respectively.EAU animal model of acute ocular inflammation was induced by bovine serum albumin(BSA).The model control group and treatment group received intravitreal injection and intravenous injection of BSA.The day after the models were operated successfully,the model control group,treatment group and normal control group were applied with NS(0.1 mL),10 g·L-1 infliximab(0.1 mL) and NS(0.1 mL) through intravitreal injection respectively.Each group was injected once.The aqueous humor of both eyes were collected separately before the rabbits were sacrificed before operation and 5 days,10 days and 15 days after operation.Meanwhile,the ocular expression was examined.ELISA method was used to detect contents of tumor necrosis factor-α(TNF-α) and interleukin-2(IL-2).The both eyes were used for histopathological examination.Results Before modeling,the level of TNF-α and IL-2 in aqueous humor among three groups was no statistical difference.At 5 days,10 days and 15 days after operation,the model control group and treatment group were significantly higher than normal control group.No significant difference was found between the model control group and treatment group at 5 days after operation(P0.05).Furthermore,at 10 days and 15 days after operation,the level of TNF-α in the model control group were(652.29±102.76)ng·L-1 and(372.63±47.59)ng·L-1,while in the treatment group the level was declined significantly to(395.88±48.97)ng·L-1 and(140.44±41.69)ng·L-1(P0.05).The level of IL-2 declined significantly to(40.89±8.81)ng·L-1 and(26.48±7.71)ng·L-1 compared to the model control group(85.55±7.74)ng·L-1 and(64.10±7.78)ng·L-1.There were no signs or pathologic change in all the rabbits in the normal control group.The histopathological examination of treatment group suggested that the inflammation significantly relieved compared to the model control group.Conclusion Infliximab can obviously inhibit the formation of TNF-α and IL-2 in aqueous humor of BAS induced EAU models,and release EAU inflammatory reaction and histological injury that can be applied to control EAU.

Key concepts: Medicine, Uveitis, Infliximab, Tumor necrosis factor alpha, Aqueous humor, Tumor necrosis factor α, Animal model, Ophthalmology

Related papers

Back to paper searchBrowse research topicsOriginal source
Curative effect of intravitreal injection of infliximab on experimental autoimmune uveitis — Research Paper | ScholarLens